"Lower dose does not mean lower responsibility." ...
GLP-1 agonists like Ozempic have exploded over the past few years, thanks to data that show they can help people lose a significant amount of weight. But these medications aren’t perfect, and it’s ...
Diet weight loss company Noom announced it is launching a new program dubbed the Noom Microdose GLP-1Rx Program, which will provide members with personalized microdoses of GLP-1 medication. The ...
New program pairs microdoses of GLP-1 medication with Noom’s powerful behavior-change program and at-home biomarker testing to track the health impact of combining GLP-1 therapy with healthy habits.
In this episode, MM+M Pharma Editor Lecia Bushak sits down with Noom’s CEO Geoff Cook and Chief Medical Officer Dr. Jeffrey Egler to discuss the launch of their new Microdose GLP-1 program, designed ...
Chapped lips, peeling skin, nosebleeds — the drug treats acne, but its side effects can be miserable. Will a lower dose help? Credit...Eric Helgas for The New York Times Supported by By Erica Sweeney ...